Testing for Irritation and Sensitization

Slides:



Advertisements
Similar presentations
EPAA Conference 5 November 2007 Georgette LALIS Enterprise and Industry DG European Commission The international dimension of regulatory acceptance.
Advertisements

EPAA Annual Conference 2007 Regulatory Acceptance and Implementation of 3Rs approaches Challenges for industry and regulators Dr. Hennicke Kamp BASF Aktiengesellschaft.
BIOLOGICAL PROPERTIES OF DENTAL MATERIALS (BIOCOMPATIBILITY)
The lymphatic system and immunity
Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
No animal test please Animal Testing and Alternatives to Animal Testing Ekatrina from Uzbekistan Tseki from Mongolia.
Animal Models for Predicting Sensitization Potential Judith C. Stadler Haskell Laboratory, DuPont Company Newark, DE.
Value of in vitro assays in your REACH dossier Frédérique van Acker 18 November 2014.
Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.
Preclinical Safety Assessment of Cosmetics & Toiletries Raman Govindarajan, MD, PhD. Regional Director Medical and Scientific Affairs Johnson and Johnson.
Page Up to Reverse  Employee Health  Page Down to Advance  Employee Health 
Introduction to Serology
DHHS / FDA / CDRH 1 Circulatory Support Devices Panel Tuesday, September 11, 2001 CoSeal® Surgical Sealant P
MB Research Laboratories New Photosensitization and Alternative Phototoxicity Methods George L. DeGeorge, Ph.D., DABT MB Research Laboratories.
Nonclinical Perspective on Initiating Phase 1 Studies for Small Molecular Weight Compounds John K. Leighton, PH.D., DABT Supervisory Pharmacologist Division.
Biomedical Research Objective 2 Biomedical Research Methods.
Biomedical Research.
Chad B. Sandusky, Ph.D. Physicians Committee for Responsible Medicine, Washington DC, USA STRATEGIES TO REDUCE ANIMAL TESTING IN US EPA’S HIGH PRODUCTION.
What is ISO 10993? How is it Different from USP Class VI?
Preclinical Guidelines: Development of Radioprotective/Mitigative Agents Departments of Dermatology & Radiation Oncology University of Rochester Medical.
MAIN TOXICITY TESTING. TESTING STRATEGIES A number of different types of data are used in order to establish the safety of chemical substances for use.
Friday, 5/2 4 Turn in “pre-lab” 4 Take out your LD50 worksheet Operating Engineers National Hazmat Program 1.
Your Body’s Defense. THE BODY’S CAPABILITY OF REMOVING OR KILLING FOREIGN SUBSTANCES, PATHOGENS AND CANCER CELLS Immunity.
Testing for Irritation and Sensitization Kenneth R. St. John, PhD Chairman F04.16 Subcommittee on Biocompatibility Test Methods.
ASTM F748 Selecting Biological Test Methods
Case Study A New Motion-Sparing Spinal Disc Replacement Kenneth R. St. John, PhD Chairman F04.16 Subcommittee on Biocompatibility Test Methods.
Contact Dermatitis.
Modified release products. Considerations in the evaluation of modified release products Requirements for preparing extended release products. The bioavailability.
ANTIMICROBIALS Chapter 10.
Analisa Stephens.  NSAID for pain and inflammation reduction ◦ Non-steroidal anti-inflammatory drugs  Localized Pain Patch ◦ Alternative to oral dosage.
Logan Gradisher Analisa Stephens. Introduction NSAID for pain and inflammation reduction – Non-steroidal anti-inflammatory drugs Localized Pain Patch.
Clinical Trials.
ASTM F748 Selecting Biological Test Methods
Elvira Maličev Blood Transfusion Centre of Slovenia
How do we culture cells in the laboratory?
Drug Synthesis Noadswood Science, 2016.
Diagnosis of cell-mediated responses
Adaptive Defense System
Immune system disease and Disorders
Immune Mediated Disorders
with Audrey Turley, B.S., RM (NRCM), CBA (ASQ)
Toxicology in Cosmetics
Treatment for Cancer.
JOJOBA Oral Gel.
Peptide Immunization Indicates that CD8+ T Cells are the Dominant Effector Cells in Trinitrophenyl-Specific Contact Hypersensitivity  Stefan Martin, Michael.
Diagnosis of cell-mediated responses
Safety Tests in Cosmetics
Safety Tests in Cosmetics
IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs  Chien-Chang Chen, PhD, Takao Kobayashi, PhD, Koji Iijima,
The lymphatic system and immunity
The Lymphatic System Pages
Xenobiotic or Drug Metabolism
Volume 21, Issue 5, Pages (November 2004)
Mucosal safety of PHI-443 and stampidine as a combination microbicide to prevent genital transmission of HIV-1  Osmond J. D'Cruz, Ph.D., Fatih M. Uckun,
ANTIMICROBIALS Chapter 10.
Good Laboratory Notebook Practices
Topical Imiquimod Treatment Prevents UV-Light Induced Loss of Contact Hypersensitivity and Immune Tolerance  Thomas H. Thatcher, Irina Luzina, Rita Fishelevich,
Immune system and Immunity
IFN-τ inhibits IgE production in a murine model of allergy and in an IgE-producing human myeloma cell line  Mustafa G. Mujtaba, PhDa, Lorelie Villarete,
Aloe Barbadensis Extracts Reduce the Production of Interleukin-10 After Exposure to Ultraviolet Radiation  Son Won Byeon  Journal of Investigative Dermatology 
TGFβ1 Overexpression by Keratinocytes Alters Skin Dendritic Cell Homeostasis and Enhances Contact Hypersensitivity  Javed Mohammed, Andrew J. Gunderson,
Chapter Fourteen Immunity
INFLAMMATION ON FIRST CONTACT INFLAMATION ON REPEATED CONTACT
Objective 2 Biomedical Research Methods
IL-23 Antagonizes UVR-Induced Immunosuppression through Two Mechanisms: Reduction of UVR-Induced DNA Damage and Inhibition of UVR-Induced Regulatory T.
Quality guidelines on impurities
Hapten-Specific Tolerance Promoted by Calcitonin Gene-Related Peptide
Dendritic Cells Require T Cells for Functional Maturation In Vivo
Epicutaneous Immunization with Autoantigenic Peptides Induces T Suppressor Cells that Prevent Experimental Allergic Encephalomyelitis  Margaret S. Bynoe,
Do Now Activity #8 List all the organs in the Lymphatic System.
Presentation transcript:

Testing for Irritation and Sensitization Kenneth R. St. John, PhD Chairman F04.16 Subcommittee on Biocompatibility Test Methods

Workshop on Medical Device Regulation Differences Irritation usually reflects the tissue response at first exposure to the material or chemical Sensitization usually refers to the response on repeat exposure, where the body has had the opportunity to develop an immune response In humans, it is not always possible to know whether a patient has previously been exposed, so knowing the potential for sensitization may prevent mild or major complications November 3, 2015 Workshop on Medical Device Regulation

Sensitizers in Medicine Incomplete list Nickel in metal alloys Latex Gloves Vial seals Needles Adhesive bandages Not necessarily addressing immune response to implants with skin tests, but the best options currently available November 3, 2015 Workshop on Medical Device Regulation

Workshop on Medical Device Regulation Tests Most experts and test documents suggest or require that materials or extracts be tested for irritation first at various doses and then the highest does for sensitization testing be the highest one that does not cause irritation Many or most tests are for skin sensitization or irritation Tests don’t really address implanted materials as well as maybe they could Tests for immune response with implantation may be useful November 3, 2015 Workshop on Medical Device Regulation

In Vivo Testing - Irritation Mucous Membrane Irritation Test – No ASTM Standard USP Irritation Test - Intracutaneous Injection Test Edema and Erythema – Analogous to USP test but not stated to be an irritation test – toxicity is emphasized but scoring is identical to F719 November 3, 2015 Workshop on Medical Device Regulation

Workshop on Medical Device Regulation Human Testing? November 3, 2015 Workshop on Medical Device Regulation

Workshop on Medical Device Regulation F719 - Irritation Clip hair from back Option to add depilatory (non-Irritating) Four sites, two intact and two abraded Place samples, two control, two test Cover with gauze and adhesive tape Wrap trunk with polyethylene film Remove after 24 hr Score at 1 hr, 24 hr, 48 hr after removal November 3, 2015 Workshop on Medical Device Regulation

Workshop on Medical Device Regulation F719 Calculate a primary irritation index, using formula in the specification, for each animal Average for all animals November 3, 2015 Workshop on Medical Device Regulation

Sensitization Testing “Sensitization of hypersensitivity reactions usually occur as a result of prolonged contact with a chemical substance that interacts with the body’s immune system. Because most such reactions to biomaterials have been of the dermal cell-mediated type, rather than the humoral or antigen-antibody type, the skin of laboratory animals is used in sensitivity testing” – Richard F. Wallin (see reference at the end of talk) November 3, 2015 Workshop on Medical Device Regulation

In Vivo Testing - Sensitization November 3, 2015 Workshop on Medical Device Regulation

In Vivo Testing - Sensitization “Biomaterials and other device materials are tested for the presence of sensitizing chemicals using guinea pigs. Guinea pig sensitization tests require six to eight weeks and thus take the longest time to complete of all the acute biocompatibility tests …” – Richard F. Wallin (see reference at the end of talk) November 3, 2015 Workshop on Medical Device Regulation

Workshop on Medical Device Regulation F720 - Sensitization Intradermal injection of an extract Three sites on each side of spine Adjuvant Sample without adjuvant Sample plus adjuvant One week later Sample in petroleum jelly or liquid on filter paper applied at each site Leave for 48 hours An additional week later Leave for 24 hours Evaluate 1 Hr, 24 hr, 48 hr later Edema/Erythema scoring system (same as F719) November 3, 2015 Workshop on Medical Device Regulation

Workshop on Medical Device Regulation F2147 - Sensitization Intended to provide a different method of exposure that the Maximization test (F720), in which false positives were seen (both methods are internationally accepted) A table of dose applications over about a 28 day period Has a useful rationale and test comparison table in the appendix November 3, 2015 Workshop on Medical Device Regulation

Workshop on Medical Device Regulation F2147 - Sensitization Same scoring matrix as F719 and F720 More variations in the challenge types and intervals of repeated doses Some experts consider this to be potentially more meaningful in actual application All applications (with or without adjuvant) to the shaved skin but no skin injections November 3, 2015 Workshop on Medical Device Regulation

Workshop on Medical Device Regulation F2148 - Sensitization Lymph nodes in mice Extract applied to both ears daily for three days On day 6 Prepare and inject a radiolabeled tracer (tritiated thymidine) Five hours later, euthanize mice Collect the auricular lymph node from each ear Mash or otherwise cut up lymph nodes into very small pieces Centrifuge and wash 3 times (PBS) Replace supernatant with Tricloroacetic acid, resuspend and precipitate overnight Replace TCA supernatant with fresh Resuspend and count redioactivity November 3, 2015 Workshop on Medical Device Regulation

F2808 – Irritation Behind the Knee Controversial – Not Accepted by US FDA Possible that only the company that advocated for it actually uses it Mostly used for over-the-counter OB/Gyn products Places material behind the knee of human volunteers 6 hours per day for 5 days Normal activities cause mechanical irritation in addition to testing chemical irritation November 3, 2015 Workshop on Medical Device Regulation

Withdrawn Standards (2011) Reflected an attempt to define in vitro tests for sensitization Withdrawal was controversial – may need to be reconsidered in the future November 3, 2015 Workshop on Medical Device Regulation

In Vitro Irritation and Sensitization International focus to reduce the number of animals used in product testing European Union Reference Laboratory for Alternatives to Animal Testing Develops and validates tests Has developed tests to assess irritation of cosmetics and chemicals A US testing laboratory is working on validating and offering in vitro tests to the medical device industry November 3, 2015 Workshop on Medical Device Regulation

In Vitro Irritation Testing Reconstructed human epidermis (RhE) Multi-Layered differentiated cell culture of human epidermis Polar and non-polar extracts MTT cytotoxicity test after exposure Assesses cell metabolic activity (viability) May become a non-animal option for irritation testing Accepted in Europe for chemicals and cosmetics EU Test Method B.46 and OECD Test Guideline (TG) 439 Would likely become a standardized method if validated Source: Medical Product Manufacturing News Sept/Oct 2015 November 3, 2015 Workshop on Medical Device Regulation

In Vitro Irritation Testing Positive control apparently has been found – is an irritant for both polar and non-polar solvents Validation will require proof of correlation with existing in vivo test results and/or clinical experience At least one US contract testing laboratory is pursuing its acceptance November 3, 2015 Workshop on Medical Device Regulation

In Vitro Sensitization Testing Three different tests are being developed One or a combination may end up being validated as non-animal tests Completion and validation is still in progress November 3, 2015 Workshop on Medical Device Regulation

Workshop on Medical Device Regulation Possible Reading Rollins, T., “Better Animal Testing Alternatives Are Coming To US,” Medical Product Manufacturing News, p.18-19, September 2015 Lister, L., “Biocompatibility Testing – Tips for Avoiding Pitfalls – Part 2,” http://mddionline.com/print/6795 Wallin, R. F., “A Practical Guide to ISO 10993-10: Sensitization,” http://mddionline.com/print/2886 Wallin, R. F., “A Practical Guide to ISO 10993-10: Irritation,” http://mddionline.com/print/2906 November 3, 2015 Workshop on Medical Device Regulation